Total Funding
49
49
Total FundingSeries E raised
Growth Score 49 in past quarter
-39 pts
Heat Score 49 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
54560
SinoTau is a total solution provider specializing in generic drugs and innovative drugs.
- Xinsheng Xu: Founder, President & Chief Executive Officer
About the Company
SinoTau is a total solution provider specializing in generic drugs and innovative drugs. They provide cardiovascular fields, neurodegeneration fields, and tumor fields. The company specializes in the early development of antibody biopharmaceuticals and is researching a variety of medicines for use in treating cancers, neurological illnesses, and
autoimmune diseases.